Skip to main content
Fig. 6 | BMC Medicine

Fig. 6

From: Levels of circulating endothelial cells are low in idiopathic pulmonary fibrosis and are further reduced by anti-fibrotic treatments

Fig. 6

Changes in the percentages of circulating endothelial cells (CEC), endothelial progenitor cells (EPC) and circulating fibrocytes in patients with idiopathic pulmonary fibrosis treated with nintedanib after 6 months of treatment. Before-and-after graphs indicate the trend of different cell populations: (a) the percentages of CEC; (b) the amount of CD309 among CEC; (c) the percentage of EPC; (d) the amount of CD309 among EPC; (e) circulating collagen I+ cells; (f) the amount of CXCR4 among fibrocytes. P-values, calculated using a Wilcoxon test for paired data, only significant values are displayed

Back to article page

BMC Medicine

ISSN: 1741-7015

Contact us